<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Aorta • SWOT analysis • Medical decision-making • Evidence-based medicine • Strategy</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
				<date type="published" when="2015-06">June 2015</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>MD, MBA</roleName><forename type="first">Yskert</forename><surname>Von Kodolitsch</surname></persName>
							<email>kodolitsch@uke.de</email>
							<affiliation key="aff1">
								<orgName type="department">Centre of Cardiology and Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">German Aorta Centre of Hamburg</orgName>
								<orgName type="institution" key="instit2">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">German</forename><forename type="middle">Aorta</forename><surname>Centre</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Alexander</forename><forename type="middle">M</forename><surname>Bernhardt</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Centre of Cardiology and Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">German Aorta Centre of Hamburg</orgName>
								<orgName type="institution" key="instit2">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, MSc</roleName><forename type="first">Peter</forename><forename type="middle">N</forename><surname>Robinson</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Institute of Medical Genetics and Human Genetics</orgName>
								<orgName type="institution">Charité Universitätsmedizin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Tilo</forename><surname>Kölbel</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Centre of Cardiology and Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">German Aorta Centre of Hamburg</orgName>
								<orgName type="institution" key="instit2">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD, PhD</roleName><forename type="first">Hermann</forename><surname>Reichenspurner</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Centre of Cardiology and Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">German Aorta Centre of Hamburg</orgName>
								<orgName type="institution" key="instit2">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sebastian</forename><surname>Debus</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Centre of Cardiology and Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">German Aorta Centre of Hamburg</orgName>
								<orgName type="institution" key="instit2">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Christian</forename><surname>Detter</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Centre of Cardiology and Cardiovascular Surgery</orgName>
								<orgName type="institution" key="instit1">German Aorta Centre of Hamburg</orgName>
								<orgName type="institution" key="instit2">University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">Centre of Cardiology</orgName>
								<orgName type="institution">Cardiovascular Surgery University Medical Centre Hamburg-Eppendorf</orgName>
								<address>
									<addrLine>Hamburg Martinistrasse 52</addrLine>
									<postCode>20246</postCode>
									<settlement>Hamburg</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Aorta • SWOT analysis • Medical decision-making • Evidence-based medicine • Strategy</title>
					</analytic>
					<monogr>
						<idno type="ISSN">2325-4637</idno>
						<imprint>
							<date type="published" when="2015-06">June 2015</date>
						</imprint>
					</monogr>
					<idno type="MD5">C82E3A550E11928B6972004D0E606E74</idno>
					<idno type="DOI">10.12945/j.aorta.2015.14.064</idno>
					<note type="submission">Received: October 17, 2014 Accepted: February 16, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:22+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: It is the physicians' task to translate evidence and guidelines into medical strategies for individual patients.</s><s>Until today, however, there is no formal tool that is instrumental to perform this translation.</s><s>Methods: We introduce the analysis of strengths (S) and weaknesses (W) related to therapy with opportunities (O) and threats (T) related to individual patients as a tool to establish an individualized (I) medical strategy (I-SWOT).</s><s>The I-SWOT matrix identifies four fundamental types of strategy.</s><s>These comprise "SO" maximizing strengths and opportunities, "WT" minimizing weaknesses and threats, "WO" minimizing weaknesses and maximizing opportunities, and "ST" maximizing strengths and minimizing threats.</s><s>Each distinct type of strategy may be considered for individualized medical strategies.</s><s>Results: We describe four steps of I-SWOT to establish an individualized medical strategy to treat aortic disease.</s><s>In the first step, we define the goal of therapy and identify all evidence-based therapeutic options.</s><s>In a second step, we assess strengths and weaknesses of each therapeutic option in a SW matrix form.</s><s>In a third step, we assess opportunities and threats related to the individual patient, and in a final step, we use the I-SWOT matrix to establish an individualized medical strategy through matching "SW" with "OT".</s><s>As an example we present two 30-year-old patients with Marfan syndrome with identical medical history and aortic pathology.</s><s>As a result of I-SWOT analysis of their individual opportunities and threats, we identified two distinct medical strategies in these patients.</s><s>Conclusion: I-SWOT is a formal but easy to use tool to translate medical evidence into individualized medical strategies.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p><s>The German Aorta Center of Hamburg (DAZ-H) is run by a team of surgeons, interventionalists and geneticists with experience in treating aortic diseases.</s><s>Our aortic diseases board holds weekly conferences for decision-making on patients with aortic disease.</s><s>In this report we describe how our board uses I-SWOT to establish individualized medical strategies for our patients <ref type="bibr" target="#b0">[1,</ref><ref type="bibr">2]</ref>.</s><s>Originally, SWOT analysis was designed to assess strengths (S) and weaknesses (W) as internal capabilities of an organization as opposed Analysis of Strengths, Weaknesses, Opportunities, and Threats as a Tool for Translating Evidence into Individualized Medical Strategies (I-SWOT) to opportunities (O) and threats (T) posed by the external environment <ref type="bibr" target="#b1">[3]</ref>.</s><s>Today, SWOT analysis is one of the world´s most widely used methods for strategic planning <ref type="bibr" target="#b2">[4,</ref><ref type="bibr" target="#b4">5]</ref>.</s><s>We use this instrument to match strengths and weaknesses of therapy with opportunities and threats related to individual patients and to establish individualized medical strategies.</s><s>Such strategies are important to systematically integrate both specific health conditions and needs, values and attitudes of patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Translation of evidence into individualized medical strategies</head><p><s>Evidence based medicine (EBM) is "the integration of the best available evidence with our clinical expertise and our patients' unique values and circumstances" <ref type="bibr" target="#b5">[6]</ref>.</s><s>However, protagonists of EBM emphasize that "evidence, whether strong or weak, is never sufficient to make clinical decisions", and that EBM "is far from a one-size-fits-all strategy" <ref type="bibr" target="#b6">[7]</ref>.</s></p><p><s>Similarly, guidelines state that "the final decisions concerning an individual patient must be made by the responsible health professional(s)" <ref type="bibr" target="#b7">[8]</ref>.</s><s>Hence, it remains the physicians´ task to translate evidence and guidelines into medical strategies for individual patients.</s><s>Until today, however there is no formal tool available to perform this translation.</s><s>Here we introduce I-SWOT as a simple and easy to use tool to accomplish this task <ref type="bibr">[2]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>The general SWOT matrix</head><p><s>At its simplest, strategy is what one may use to reach goals.</s><s>SWOT analysis regards as "internal capabilities" all those factors that a strategic planner contributes himself to reaching a goal.</s><s>Depending on whether these capabilities support or jeopardize attaining goals, SWOT analysis terms these factors "strengths" or "weaknesses".</s><s>Conversely, SWOT analysis regards as "external possibilities" all factors that the strategic planner does not control directly.</s><s>Depending on whether these possibilities support or jeopardize goals, SWOT analysis terms these factors "opportunities" or "threats".</s><s>In our SWOT analysis physicians take the role of the strategic planner, where we call "strengths" or "weaknesses" those factors of therapy that relate to both the efficacy of a medication or an intervention, and the physician´s capability to deliver such therapy.</s><s>"Opportunities" or "threats" are those factors of therapy that mostly relate to patients, such as the disease that requires treatment, the health status of the patient, or the motivation or capability to support therapy.</s></p><p><s>Matching strengths and weaknesses with opportunities and threats identifies four distinct types of strategy <ref type="bibr" target="#b0">[1]</ref> (Figure <ref type="figure" target="#fig_0">1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>SO strategy</head><p><s>This strategy maximizes both internal strengths and external opportunities ("Maxi-maxi" strategy) <ref type="bibr" target="#b1">[3]</ref>.</s><s>The strategy might be chosen in a cheerful situation strategy).</s><s>The strategy may be chosen in bail-out situations where maximizing own strengths may be the only way to overcome substantial threats.</s><s>For instance, a surgeon may treat a Crawford Type II expanding aortic dissection through replacement of the entire descending thoracoabdominal aorta <ref type="bibr" target="#b9">(10)</ref>.</s><s>This doctor overcomes the substantial threat given by an expanding Crawford Type II dissection ("T") by using his own capabilities ("S") to perform extensive surgery with exceptionally good results.</s></p><p><s>However, in such situations doctors may avoid to exaggerate reliance on their own capabilities.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Four steps of I-SWOT to establish an individualized medical strategy</head><p><s>At our center, we perform four steps to establish an individualized medical strategy to treat aortic disease (Figure <ref type="figure" target="#fig_1">2</ref>). 1. Define the goal of therapy and identify all evidence-based therapeutic options.</s><s>The patients discussed in our aortic diseases board present with decision problems that are related to aortic disease.</s><s>In the following, we present our discussion of a 30-year old man with a disease-causing FBN1 mutation and clinical criteria of Marfan syndrome (MFS).</s><s>His aortic root diameter had progressed from 4.3 cm to 4.6 within one year.</s><s>The goal of therapy is to protect this patient with an aortic root aneurysm against dissection.</s><s>We identified the following 5 options which were available according to the literature <ref type="bibr" target="#b10">[11]</ref><ref type="bibr" target="#b11">[12]</ref><ref type="bibr">[13]</ref>:</s></p><p><s>• Medical treatment with beta-blockers (BAB) <ref type="bibr" target="#b13">[14]</ref>, or angiotensin II-receptor blockers (ARB) <ref type="bibr" target="#b14">[15]</ref>; • Elective surgery of the aortic root including personalized external aortic root support <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b15">16]</ref>; • Aortic-valve-sparing reimplantation technique according to David <ref type="bibr" target="#b16">[17]</ref>; • Composite valve grafting according to Bentall with bio-aortic valve prosthesis <ref type="bibr" target="#b17">[18]</ref>; or • Composite valve grafting according to Bentall with a mechanical valve <ref type="bibr" target="#b18">[19]</ref>.</s><s>In addition, we define the prognosis of aortic root aneurysm and the need for timing of an intervention.</s><s>With an aortic diameter of 4.6 cm most guidelines would consider surveillance and BAB with abundant own strengths and auspicious external opportunities.</s><s>For example, well-established standard procedures are available for surgery of aortic root aneurysm, but a skilled surgeon may perform a promising but not yet-established operation in a healthy and motivated patient <ref type="bibr" target="#b8">[9]</ref>.</s><s>This surgeon maximizes exploit of strengths ("S") given by his skills to accomplish the operation where he takes opportunity ("O") of motivation and relatively good health of his patient.</s><s>However, in such situations doctors may overrate their prospects.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>WT strategy</head><p><s>This strategy minimizes both weaknesses and threats ("Mini-mini" strategy) <ref type="bibr" target="#b1">[3]</ref>.</s><s>The strategy might be chosen in a precarious situation in which strengths are sparse and threats are mounting.</s><s>For example, a doctor may resort to purely medical therapy of a patient with an acute Type A dissection in a hospital without heart surgery.</s><s>This doctor minimizes the weakness of therapeutic options in his clinic through applying the easily available but hardly effective medical therapy of Type A dissection ("W"), and he minimizes threats ("T") by avoiding transportation of an unstable patient to another hospital.</s><s>Doctors may strive to escape precarious situations and seek for other strategies.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>WO strategy</head><p><s>This opportunity-focused strategy minimizes weaknesses and maximizes opportunities ("Minimaxi" strategy) <ref type="bibr" target="#b1">[3]</ref>.</s><s>The strategy may be chosen in a situation where therapeutic options are severely restricted ("W") while external opportunities ("O") are promising.</s><s>For instance, the doctor mentioned above might order a helicopter to get his patient into a surgical center.</s><s>This doctor minimizes weaknesses ("W") of treating aortic dissection in his own clinic by maximizing opportunities ("O") of patient survival in another clinic.</s><s>In the WO position doctors may seek to reinforce their own strengths to get better control over therapy.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ST strategy</head><p><s>This strength-focused strategy maximizes own strengths and minimizes threats ("Maxi-mini"  strength-weakness (SW) matrices for each option, where we integrate information from studies, case reports, guidelines, and from our own experience.</s><s>Table <ref type="table" target="#tab_0">1</ref> shows the SW-matrix for treating aortic root aneurysm in MFS (Table <ref type="table" target="#tab_0">1</ref>).</s><s>3. Assess opportunities and threats related to the individual patient (OT-matrix).</s><s>The core of an individualized treatment strategy is to adjust treatment plans to the individual patient <ref type="bibr" target="#b0">[1,</ref><ref type="bibr">2]</ref>.</s><s>The patient may have physical, psychological or mental health conditions, individual wills, needs, beliefs, values, risk attitudes, and emotions that may speak in favor of or against specific therapeutic strategies.</s><s>Again, we screen the literature and medication with surgery indicated only when a diameter ≥ 5.0 cm is reached.</s><s>However, the patient had exhibited progression of 0.3 cm of his aortic diameter within one year; evidence and guidelines yielded conflicting data as to whether this was a risk factor to initiate surgery already at ≥ 4.5 cm <ref type="bibr" target="#b7">[8,</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref>. Finally we concluded that based on a simple analysis of evidence all five therapeutic options remained acceptable options for treatment of our patient.</s><s>2. Assess strengths and weaknesses of each therapeutic option (SW-matrix).</s><s>The first step of I-SWOT analysis is to assess strengths and weaknesses of each therapeutic option.</s><s>We establish  von Kodolitsch, Y. et al.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>I-SWOT for Individualized Medical Strategies</head><p><s>discuss our personal experience to comprehensively assess patient conditions which may interfere with outcomes of therapy.</s><s>Table <ref type="table" target="#tab_1">2</ref> displays our opportunities-and-threats matrix (OT matrix) of assessing adult MFS patients for elective surgery.</s><s>4. Use I-SWOT to establish an individualized medical strategy.</s><s>The final step to an individualized medical strategy is to match strengths and weaknesses of therapeutic options with opportunities and threats related to the individual patient.</s><s>We present results from the systematic audit of strengths and weaknesses in the top row of the SWOT matrix, where we use standardized forms which allow us to prepare SWOT matrices for various aortic disease entities.</s><s>Since most strengths and weaknesses relate to more than one therapeutic option, we list strengths and weaknesses in the final I-SWOT matrix regardless of specific therapeutic options.</s><s>For example, in the final I-SWOT matrix we list "no oral anticoagulation" as strength "S3", which relates to therapeutic options 1-4, or "patient-prosthesis mismatch" as weakness "W8", which relates to therapeutic options 4 and 5 (Table <ref type="table" target="#tab_0">1</ref>; Figure <ref type="figure" target="#fig_2">3</ref>).</s><s>Conversely, in the left column of the I-SWOT matrix we list individualized results from the audit of patient-related opportunities and threats.</s><s>For instance, good health without comorbidity may be entered into the I-SWOT matrix as an opportunity for treatment in the "health status domain", which corresponds to domain 4 of our OT matrix ("O4"; Table <ref type="table" target="#tab_1">2</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>I-SWOT exemplified</head><p><s>As the basic example we use the Marfan patient mentioned above.</s><s>Imagine him to be an active cyclist in good health (O4) who had undergone surgical closure of a ventricular septal defect in childhood (T4; Figure <ref type="figure" target="#fig_4">4</ref>).</s><s>Accordingly, an SO strategy might be to perform an aortic-valve-sparing reimplantation operation according to David to maximize outcome through advanced surgical techniques (S3-5, S7), and promote the patient´s good health and participation in sports activities (O4), whereas a WT strategy might be medical treatment to minimize surgical trauma (W3-8) and minimize the likelihood of a third heart operation (T4).</s><s>A WO strategy might be to perform a composite valve grafting according to Bentall with a bio-aortic valve prosthesis to minimize surgical risk (W4, W6), be convinced to undergo a mechanical Bentall operation and then to personally self-control INR values throughout his life (ST type of strategy) (Figure <ref type="figure" target="#fig_4">4</ref>).</s></p><p><s>Patient 2. Imagine, the same patient to be a professional rock drummer living a "no risk, no fun" life style.</s><s>He might feel perfect about taking a David operation once and then get rid of major health troubles for the next couple of years (SO type of strategy).</s></p><p><s>Patient 3.</s><s>Alternatively, the above mentioned patient is a doctor of anthropology, who cannot be dissuaded from maximizing his professional career by living with natives in a tropical moist forest for the next 5 years (O3).</s><s>For him, a bio-Bentall minimizes the but to maximize the patient´s sports opportunities by avoiding anticoagulation (O4).</s><s>Finally, a ST strategy might be to perform a composite valve grafting according to Bentall with a mechanical valve to maximize therapeutic durability (S9, S10), and to minimize the likelihood of a third heart operation (T4).</s></p><p><s>We present four examples with variations in the individual attitude and character of this patient.</s><s>We show how these variations influence I-SWOT based decisions, where each example relates to one of the four distinct types of strategy.</s></p><p><s>Patient 1.</s><s>In our first example, the above mentioned patient is a highly accurate (O3) and risk-avoiding bureaucrat (T3), who might at best</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conclusions</head><p><s>We identify specific advantages of SWOT analysis to translate evidence into individual medical strategies.</s><s>SWOT analysis is a formal way to support the systematic integration of the patient and their individual issues into medical strategies.</s><s>With our technique of standardizing evidence-based SW matrices of therapies, I-SWOT saves rather than costs time in the decision-making process.</s><s>I-SWOT reminds us to consider four basic options of strategy rather than just a single one, which might be, for instance, only to seek exploiting the maximum of strengths and opportunities <ref type="bibr" target="#b1">[3]</ref>.</s><s>Practice guidelines may provide SW matrices of treatment options to provide standardized support for individualized medical decisions.</s></p><p><s>Moreover, I-SWOT may be used in case studies as an instrument to teach individualized medical decision-making.</s><s>Finally, we believe that I-SWOT is a simple approach to holism in medical strategy, which encourages to integrate attitudes and values of both doctors and patients.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>I-SWOT adds important aspects to tacit or intuitive SWOT-ing:</head><p><s>First, it provides an explicit and rational method that explains how evidence actually translates into individualized strategies; future treatment guidelines may take advantage of I-SWOT and establish SW matrices for specific goals of treatment.</s><s>Second, I-SWOT allows physicians to make transparent, to discuss, to criticize and to teach where, why and how they make specific choices of strategy.</s><s>Third, whereas simple-minded protagonists of EBM tend to understand variation of medical practice exclusively as a sign of malpractice, I-SWOT shows why such variation may reflect a wise physicians' respect of his patient as an individual with an own personality.</s><s>Fourth, especially for decisions debated in groups it may be helpful to agree on a common method of how to make decisions.</s><s>Finally, the formalization of I-SWOT can vary: one may do it quickly and tacitly, one may use standardized I-SWOT matrix forms as shown in Figure <ref type="figure" target="#fig_2">3</ref> and Figure <ref type="figure" target="#fig_4">4</ref>, and another one may even weigh all different strengths, weaknesses, opportunities and threats using score points.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.">Can you describe for us how the process of SWOT</head><p><s>analysis proceeds in your Aortic Board meetings?</s><s>Does one individual prepare an analysis before the meeting?</s><s>Is the analysis prepared after the meeting?</s><s>Does the team go to the literature for each case, or do they know the literature and just input their knowledge?</s><s>Please help us to understand the process.</s></p><p><s>A physician presents their patient including history, medical findings, comorbidities, CT-images and so on.</s><s>Then we formulate the goal of therapy and identify the options for treatment.</s><s>We start establishing firm SW matrices for different goals of aortic therapy (Table <ref type="table" target="#tab_0">1</ref>).</s><s>However, for "standard" goals of aortic therapy we do not use these matrices.</s><s>In a next step, we discuss specific opportunities and threats related to the patient, where we ask questions about all domains as outlined in the OT matrix (Table <ref type="table" target="#tab_1">2</ref>).</s><s>This works well for assessing individual medical and social issues of a patient (O4/T4; O6/T6; O7/T8).</s><s>However, the conference setting imposes serious limits to the audit of complex and subjective domains of the OT matrix.</s><s>Domains such as will (O1/T1), needs (O2/T2), values (O3/T3), intellect (O5/T5), and emotions (O9/ T9) require an intense dialogue with the patient.</s><s>Such dialogue is difficult to delegate to the physician who presents the patient.</s><s>In a final step, we formulate an individualized medical strategy and designate which of our Board members actually performs therapy.</s><s>This person discusses our suggestion of strategy with the patient and re-assesses the patients´ will, values and attitudes.</s><s>It happens in a considerable quantity of individuals that we change strategies after intense dialogue with the patient.</s><s>Then we adjust strategies and another colleague may take over the further management.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.">Do you know of other teams that use I-SWOT actively in clinical care in the aortic arena or in any other disease entity?</head><p><s>No. No other team uses I-SWOT with clear reference to this method.</s><s>We wrote the article to inform and encourage colleagues to try out this tool: Guidelines may provide SW matrices for specific treatment goals, as mentioned.</s><s>Clinical decision-makers may assess OT matrices of each patient with complex decisions where they really assess the patients´ will, needs, values, intellect, and emotions.</s><s>Intense dialogue with patients is important to make best use of the potential benefits of I-SWOT.</s><s>So, who uses I-SWOT "unknowingly" already and who may probably use I-SWOT in the future?</s><s>Any physician who strives for medical decisions and respects the patient as a unique individual.</s><s>That is why we are confident that I-SWOT will find friends outside the Hamburg Aorta Centre.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>The general SWOT matrix.</s></p></div></figDesc><graphic coords="2,137.56,70.75,337.15,189.65" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Four steps to establish an individualized medical strategy.</s></p></div></figDesc><graphic coords="4,137.56,70.87,337.15,189.65" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc><div><p><s>Figure 3. Example for a standardized I-SWOT matrix form.</s></p></div></figDesc><graphic coords="4,137.56,285.86,337.15,392.35" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>( 5 )</head><label>5</label><figDesc><div><p><s>CVG according to Bentall with mechanical AVR Life-long durability of AVR (S9); Classic gold standard procedure (S10) Patient-prosthesis mismatch (W8); Oral anticoagulation (W9); High risk of endocarditis (W10); Noise of mechanical valve (W11) ARB = angiotensin-II-receptor blockers; AVD = aortic valve dysfunction (either of the native valve or of a bio-prosthesis); AVS = aortic-valve-sparing operation; AVR = aortic valve replacement; CVG = composite valve grafting; and SW = strength and weaknesses.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Figure 4 .</head><label>4</label><figDesc><div><p><s>Figure 4.</s><s>The use I-SWOT to establish an individualized medical strategy in a 30-year old male Marfan patient with an aortic root aneurysm ("Patient 1" as discussed in the text).</s></p></div></figDesc><graphic coords="7,137.56,70.87,337.15,395.75" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Strengths-weaknesses matrix of specific options to treat aortic root aneurysm in Marfan syndrome.</s></p></div></figDesc><table><row><cell>Treatment option</cell><cell>Strengths</cell><cell>Weaknesses</cell></row><row><cell>(1) Wait and medicate</cell><cell>Prevention of surgical trauma (S1);</cell><cell>Protection against aortic root rupture</cell></row><row><cell></cell><cell>ARB may cure aortic disease in some patients (S2); Other strengths: S3-S6</cell><cell>and aortic valve regurgitation is not safe especially at aortic diameters &gt; 5.0 cm (W1); Patient may be nonresponders to drugs</cell></row><row><cell></cell><cell></cell><cell>or may have drug reaction (W2)</cell></row><row><cell>(2) Personalized external</cell><cell>No oral anticoagulation (S3);</cell><cell>Innovative therapy with little data on</cell></row><row><cell>aortic root support</cell><cell>Preservation of native aortic valve (S4); Low risk of endocarditis (S5); Avoidance of cardiopulmonary bypass (S6)</cell><cell>long-term outcome, where intervention is performed at 4-4.5-cm diameters when surgery is usually not indicated (W3); High level of expertise (W4);</cell></row><row><cell></cell><cell></cell><cell>Operation is not performed at DAZ-H</cell></row><row><cell></cell><cell></cell><cell>(W5)</cell></row><row><cell>(3) AVS re-implantation technique according</cell><cell>No oral anticoagulation (S3);</cell><cell>High level of expertise required (W4);</cell></row><row><cell>to David</cell><cell>Avoidance of prosthesis-patient mis-</cell><cell>Long clamping time (W6);</cell></row><row><cell></cell><cell>match (S4);</cell><cell>Reoperation for AVD (W7)</cell></row><row><cell></cell><cell>Low risk of endocarditis (S5);</cell><cell></cell></row><row><cell></cell><cell>Good results at DAZ-H (S7)</cell><cell></cell></row><row><cell>(4) CVG according to Bentall with Bio-AVR</cell><cell>No oral anticoagulation (S3);</cell><cell>Reoperation for AVD (W7);</cell></row><row><cell></cell><cell>Shorter clamping-time and easier to</cell><cell>Patient-prosthesis mismatch (W8)</cell></row><row><cell></cell><cell>perform than AVS (S8)</cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 2 .</head><label>2</label><figDesc><div><p><s>OT Matrix for assessing the individual patient</s></p></div></figDesc><table><row><cell>Domain</cell><cell>Opportunity or threat?</cell></row><row><cell>Will</cell><cell>Is the patients´ will clear, strong and sta-</cell></row><row><cell>(O1/T1)</cell><cell>ble or unclear, weak and fluctuating?</cell></row><row><cell></cell><cell>Does the patient want to follow best</cell></row><row><cell></cell><cell>medical advice or does he refuse or</cell></row><row><cell></cell><cell>request specific measures?</cell></row><row><cell>Needs</cell><cell>Does the patient have needs in his private</cell></row><row><cell>(O2/T2)</cell><cell>life, profession, or spare-time activities that support or threaten therapy?</cell></row><row><cell>Beliefs, values, risk</cell><cell>Are there religious beliefs (e.g., Jehovah's</cell></row><row><cell>attitude</cell><cell>Witness), values (e.g., refusal of surgery</cell></row><row><cell>(O3/T3)</cell><cell>before finishing his master degree), or risk</cell></row><row><cell></cell><cell>attitudes (e.g., being particularly anxious</cell></row><row><cell></cell><cell>or frivolous)?</cell></row><row><cell>Health status</cell><cell>Is there diagnostic uncertainty about the</cell></row><row><cell>(O4/T4)</cell><cell>aortic pathology or etiology of disease?</cell></row><row><cell></cell><cell>Are there allergies or contraindications</cell></row><row><cell></cell><cell>against BAB, ARB, ACE-inhibitors, or</cell></row><row><cell></cell><cell>anticoagulants? Do certain conditions</cell></row><row><cell></cell><cell>jeopardize surgical or interventional</cell></row><row><cell></cell><cell>success (e.g., bleeding disorders, aortic</cell></row><row><cell></cell><cell>and cardiac anatomy)? Is the patient</cell></row><row><cell></cell><cell>in good health, of young age, does he</cell></row><row><cell></cell><cell>have endurance, other organ diseases, or</cell></row><row><cell></cell><cell>multi-morbidity?</cell></row><row><cell>Intellect</cell><cell>Does the patient have a high or low level</cell></row><row><cell>(O5/T5)</cell><cell>of education, breadth of understanding?</cell></row><row><cell></cell><cell>Is he well informed, or able to understand</cell></row><row><cell></cell><cell>complex courses of argument or action?</cell></row><row><cell></cell><cell>Does he have restrictions of intellect such</cell></row><row><cell></cell><cell>as dementia?</cell></row><row><cell>Psychiatric status</cell><cell>Does the patient have a stable psycho-</cell></row><row><cell>(O6/T6)</cell><cell>logical status? Does he have restrictions</cell></row><row><cell></cell><cell>in his behavior imposed through diseases</cell></row><row><cell></cell><cell>such as depression or schizophrenia?</cell></row><row><cell>Sociology</cell><cell>Does the patient have supportive or rath-</cell></row><row><cell>(O7/T8)</cell><cell>er complicating social resources (health insurance, housing conditions, and eco-</cell></row><row><cell></cell><cell>nomic conditions) and environment (e.g.,</cell></row><row><cell></cell><cell>family, friends, or profession)?</cell></row><row><cell>Emotions</cell><cell>Does the patient have high or low trust</cell></row><row><cell>(O9/T9)</cell><cell>in health professionals? Does the patient</cell></row><row><cell></cell><cell>have high or low confidence in medical</cell></row><row><cell></cell><cell>success and in his future prospects? Does</cell></row><row><cell></cell><cell>he have an optimistic or rather a pessimis-</cell></row><row><cell></cell><cell>tic attitude? Does the patient have high</cell></row><row><cell></cell><cell>or low motivation for intervention?</cell></row><row><cell cols="2">OT identifies opportunities and threats related to the individual patient</cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Acknowledgment</head><p><s>The authors wish to thank Michael Schlüter and Arnim Sachweh for their valuable contributions to the discussion of the paper, and also Reed E. Pyeritz for his thoughtful and encouraging comments.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Conflict of Interest</head><p><s>The authors have no conflict of interest relevant to this publication.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Comment on this Article or Ask a Question</head><p><s>risks of both anticoagulation and reoperation during his life without access to modern health care (WO type of strategy).</s></p><p><s>Patient 4. Finally, we may imagine our patient to be a skeptical high school teacher who is single and spends his spare time in a Yoga gym (T3).</s><s>He distrusts brachial western surgery and presently can identify himself only with regular ultrasound surveillance and medical therapy hoping that the aorta stays at a steady diameter (WT type of strategy).</s></p><p><s>All four examples represent variations in the individual attitude and character of the patient.</s><s>However, there could be variation in all other dimensions listed in the OT-matrix (Table <ref type="table">2</ref>).</s><s>Imagine that "patient 4" was diagnosed of having MFS without confirmation by FBN1 sequencing (O4/T4).</s><s>Considering the hazards of a WT strategy in this patient we would suggest molecular analysis.</s><s>Imagine that a disease-causative mutation is located in the TGFBR2 gene rather than in the FBN1 gene: the diagnosis then is Loeys-Dietz syndrome rather than MFS.</s><s>As a consequence, the risk of an aortic root aneurysm with 4.6 cm diameter is much higher than in MFS and we definitively would try anything to convince the patient to move away from a WT type of strategy to any strategy that offers a definitive prevention of rupture of the Loeys-Dietz aorta.</s></p><p><s>Taken all these example together, we have shown that as a result of I-SWOT, we identify distinct individualized medical strategies depending on different characteristics of patients.</s><s>In our aorta board we establish a final individualized medical strategy only through discussion between all medical disciplines represented in our board and, most importantly, through discussion with our patients.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Strategic thinking as the key to surgical excellence. Medical thought style in the tradition of Kant and Clausewitz</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Von Kodolitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Bernhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kölbel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Detter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Reichenspurner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Es ;</forename><surname>Debus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Von Kodolitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Overlack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kodolitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bernhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Detter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Epskamp</surname></persName>
		</author>
		<idno type="DOI">10.1007/s00398-013-1018-y</idno>
		<idno>DOI: 10.1007/s00398-013-1018-y</idno>
	</analytic>
	<monogr>
		<title level="j">Z Herz-Thorax-Gefäßchir</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="282" to="289" />
			<date type="published" when="2013">2015. 2013</date>
		</imprint>
	</monogr>
	<note>Maximizing therapeutic success: The key concepts of individualized medical strategy (IMS)</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">The TOWS matrix: A tool for situational analysis</title>
		<author>
			<persName><forename type="first">H</forename><surname>Weihrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Strategic Planning: Models and Analytical Techniques</title>
				<editor>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Dyson</surname></persName>
		</editor>
		<imprint>
			<publisher>Wiley</publisher>
			<date type="published" when="1990">1990</date>
			<biblScope unit="page" from="17" to="36" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main">Ahlstr B. Strategy safari: a guided tour through the wilds of strategic management</title>
		<author>
			<persName><forename type="first">H</forename><surname>Mintzberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">W</forename><surname>Ahlstrand</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lampel</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<monogr>
		<title level="m">Simon &amp; Schuster Adult Publishing Group</title>
				<meeting><address><addrLine>New York</addrLine></address></meeting>
		<imprint>
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Swot Methodology: A State-of-the-Art Review for the Past, A Framework for the Future</title>
		<author>
			<persName><forename type="first">S</forename><surname>Ghazinoory</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abdi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Azadegan-Mehr</surname></persName>
		</author>
		<idno type="DOI">10.3846/16111699.2011.555358</idno>
	</analytic>
	<monogr>
		<title level="j">J Bus Econ Manage</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="24" to="48" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Evidence based medicine: what it is and what it isn&apos;t</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Sackett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Rosenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Richardson</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.312.7023.71</idno>
		<idno>DOI: 10.1136/ bmj.312.7023.71</idno>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">312</biblScope>
			<biblScope unit="page" from="71" to="72" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Misunderstandings, misperceptions, and mistakes</title>
		<author>
			<persName><forename type="first">S</forename><surname>Straus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Haynes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Glasziou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Dickersin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Guyatt</surname></persName>
		</author>
		<idno type="DOI">10.1136/ebm.12.1.2-a</idno>
	</analytic>
	<monogr>
		<title level="j">Evid Based Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2-3</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC)</title>
		<author>
			<persName><forename type="first">R</forename><surname>Erbel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Aboyans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boileau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bossone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Bartolomeo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Eggebrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehu281</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="2873" to="2926" />
			<date type="published" when="2014">2014. 2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">The Tailor of Gloucester: a jacket for the Marfan&apos;s aorta</title>
		<author>
			<persName><forename type="first">T</forename><surname>Golesworthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lamperth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mohiaddin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pepper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Thornton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Treasure</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0140-6736(04)17308-X</idno>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">364</biblScope>
			<biblScope unit="page">1582</biblScope>
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">The Thoracoabdominal Aorta in Marfan Syndrome</title>
		<author>
			<persName><forename type="first">S</forename><surname>Lemaire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>De La Cruz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Coselli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Bonser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haverich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mascaro</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-1-4471-5622-2_37</idno>
	</analytic>
	<monogr>
		<title level="m">Controversies in Aortic Dissection and Aneurysmal Disease</title>
				<meeting><address><addrLine>London</addrLine></address></meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2014">2014</date>
			<biblScope unit="page" from="423" to="434" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">When should surgery be performed in Marfan Syndrome and other connective tissue disorders to protect against type a dissection?</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Von Kodolitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Robinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Bonser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pagano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Haverich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mascaro</surname></persName>
		</author>
		<idno type="DOI">10.1007/978-1-4471-5622-2_2</idno>
	</analytic>
	<monogr>
		<title level="m">Controversies in Aortic Dissection and Aneurysmal Disease</title>
				<meeting><address><addrLine>London</addrLine></address></meeting>
		<imprint>
			<publisher>Springer</publisher>
			<date type="published" when="2014">2014</date>
			<biblScope unit="page" from="17" to="47" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Management of aortic disease in Marfan Syndrome: a decision analysis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">Y</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Hsia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Pyeritz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Albert</surname></persName>
		</author>
		<idno type="DOI">10.1001/archinte.165.7.749</idno>
		<idno>DOI: 10.1001/ archinte.165.7.749</idno>
	</analytic>
	<monogr>
		<title level="j">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="page" from="749" to="755" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Comparison of aortic root replacement in patients with Marfan syndrome</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Bernhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Treede</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rybczynski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sheikzadeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Kersten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Meinertz</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.ejcts.2011.02.018</idno>
	</analytic>
	<monogr>
		<title level="j">Eur J Cardiothorac Surg</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1052" to="1057" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan&apos;s syndrome</title>
		<author>
			<persName><forename type="first">J</forename><surname>Shores</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Berger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Murphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Pyeritz</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJM199405123301902</idno>
		<idno>DOI: 10.1056/ NEJM199405123301902</idno>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">330</biblScope>
			<biblScope unit="page" from="1335" to="1341" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Groenink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Den Hartog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Franken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Radonic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>De Waard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Timmermans</surname></persName>
		</author>
		<idno type="DOI">10.1093/eu-rheartj/eht334</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="3491" to="3500" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Personalised external aortic root support (PEARS) in Marfan syndrome: analysis of 1-9 year outcomes by intention-to-treat in a cohort of the first 30 consecutive patients to receive a novel tissue and valve-conserving procedure, compared with the published results of aortic root replacement</title>
		<author>
			<persName><forename type="first">T</forename><surname>Treasure</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Takkenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Golesworthy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Petrou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Rosendahl</surname></persName>
		</author>
		<idno type="DOI">10.1136/heartjnl-2013-304913</idno>
	</analytic>
	<monogr>
		<title level="j">Heart</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="969" to="975" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">An aortic valvesparing operation for patients with aortic incompetence and aneurysm of the ascending aorta</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Feindel</surname></persName>
		</author>
		<idno type="PMID">1532219</idno>
	</analytic>
	<monogr>
		<title level="j">J Thorac Cardiovasc Surg</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="617" to="621" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Composite aortic root replacement with a bovine pericardial valve conduit</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Hilgenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Mora</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0003-4975(02)04510-1</idno>
	</analytic>
	<monogr>
		<title level="j">Ann Thorac Surg</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="4510" to="4511" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">A technique for complete replacement of the ascending aorta</title>
		<author>
			<persName><forename type="first">H</forename><surname>Bentall</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Bono</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename></persName>
		</author>
		<idno type="DOI">10.1136/thx.23.4.338</idno>
		<idno>DOI: 10.1136/ thx.23.4.338</idno>
	</analytic>
	<monogr>
		<title level="j">Thorax</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="338" to="339" />
			<date type="published" when="1968">1968</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Guidelines for the diagnosis and management of Marfan syndrome</title>
		<author>
			<persName><forename type="first">L</forename><surname>Ades</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.hlc.2006.10.022</idno>
		<idno>DOI: 10.1016/j. hlc.2006.10.022</idno>
	</analytic>
	<monogr>
		<title level="j">Heart Lung Circ</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="28" to="30" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Consensus Conference on the management of adults with congenital heart disease: outflow tract obstruction, coarctation of the aorta, tetralogy of Fallot, Ebstein anomaly and Marfan&apos;s syndrome</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Silversides</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kiess</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Beauchesne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Bradley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Connelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Niwa</surname></persName>
		</author>
		<idno type="DOI">10.1016/S0828-282X(10)70355-X</idno>
	</analytic>
	<monogr>
		<title level="j">Can J Cardiol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page">70355</biblScope>
			<date type="published" when="2009">2009. 2010</date>
		</imprint>
	</monogr>
	<note>Canadian Cardiovascular Society</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Hiratzka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Bakris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Beckman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Bersin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">F</forename><surname>Carr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Casey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jr</forename></persName>
		</author>
		<idno type="DOI">10.1161/CIR.0b013e3181d4739e</idno>
		<idno>DOI: 10.1161/ CIR.0b013e3181d4739e</idno>
		<ptr target="ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM" />
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="e266" to="369" />
			<date type="published" when="2010">2010. 2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Aortic root growth in men and women with the Marfan&apos;s syndrome</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Meijboom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Timmermans</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Zwinderman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Engelfriet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Mulder</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.amjcard.2005.06.094</idno>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="1441" to="1444" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vahanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Baumgartner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bax</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Butchart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Filippatos</surname></persName>
		</author>
		<idno type="DOI">10.1093/eurheartj/ehl428</idno>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="230" to="268" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
